Cyclosporine a Pretreatment and Kidney Graft Function

PHASE4CompletedINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

April 10, 2022

Study Completion Date

April 3, 2023

Conditions
Brain DeathKidney Transplantation
Interventions
DRUG

cyclosporine A

the intervention group receives 2.5 mg/kg of cyclosporine

DRUG

Placebo

control group receives a placebo

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

University Hospital, Estaing

OTHER

collaborator

Centre Hospitalier Universitaire de Nice

OTHER

collaborator

Groupe Hospitalier Pitie-Salpetriere

OTHER

collaborator

Centre Hospitalier Universitaire de Nīmes

OTHER

collaborator

University Hospital, Montpellier

OTHER

collaborator

Hôtel Dieu (Nantes)

UNKNOWN

collaborator

Poitiers University Hospital

OTHER

collaborator

University Hospital, Toulouse

OTHER

collaborator

Hôpital de la Timone

OTHER

lead

University Hospital, Clermont-Ferrand

OTHER

NCT02907554 - Cyclosporine a Pretreatment and Kidney Graft Function | Biotech Hunter | Biotech Hunter